LIR Life Sciences Corp. (CSE:SKNY)

Canada flag Canada · Delayed Price · Currency is CAD
0.930
+0.010 (1.09%)
At close: Mar 5, 2026
106.67%
Market Cap 25.92M
Revenue (ttm) n/a
Net Income (ttm) -566.64K
Shares Out 27.87M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,501
Average Volume 34,913
Open 0.980
Previous Close 0.920
Day's Range 0.930 - 0.980
52-Week Range 0.450 - 2.410
Beta n/a
RSI 30.19
Earnings Date Mar 31, 2026

About LIR Life Sciences

LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada. [Read more]

Industry Pharmaceutical Preparations
Founded 2024
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol SKNY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.